Nothing Special   »   [go: up one dir, main page]

HK1064048A1 - Aqueous dispersion comprising stable nanoparticlesof a water-insoluble active and an excipient like middle chain triglycerides (mct) - Google Patents

Aqueous dispersion comprising stable nanoparticlesof a water-insoluble active and an excipient like middle chain triglycerides (mct)

Info

Publication number
HK1064048A1
HK1064048A1 HK04106826A HK04106826A HK1064048A1 HK 1064048 A1 HK1064048 A1 HK 1064048A1 HK 04106826 A HK04106826 A HK 04106826A HK 04106826 A HK04106826 A HK 04106826A HK 1064048 A1 HK1064048 A1 HK 1064048A1
Authority
HK
Hong Kong
Prior art keywords
water
stable
nanoparticlesof
mct
excipient
Prior art date
Application number
HK04106826A
Other languages
English (en)
Inventor
Pia Margaretha Cecilia Skantze
Tommy Urban Skantze
Lars Christian Von Corswant
Schantz Anna Elisab Zackrisson
Per Lennart Lindfors
Ulf Olsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0119081A external-priority patent/GB0119081D0/en
Priority claimed from GB0212463A external-priority patent/GB0212463D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1064048A1 publication Critical patent/HK1064048A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
HK04106826A 2001-08-06 2004-09-08 Aqueous dispersion comprising stable nanoparticlesof a water-insoluble active and an excipient like middle chain triglycerides (mct) HK1064048A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0119081A GB0119081D0 (en) 2001-08-06 2001-08-06 Process
GB0212463A GB0212463D0 (en) 2002-05-30 2002-05-30 Process
PCT/GB2002/003583 WO2003013472A1 (en) 2001-08-06 2002-08-01 Aqueous dispersion comprising stable nanoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct)

Publications (1)

Publication Number Publication Date
HK1064048A1 true HK1064048A1 (en) 2005-01-21

Family

ID=26246405

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04106826A HK1064048A1 (en) 2001-08-06 2004-09-08 Aqueous dispersion comprising stable nanoparticlesof a water-insoluble active and an excipient like middle chain triglycerides (mct)

Country Status (20)

Country Link
US (1) US20050009908A1 (el)
EP (1) EP1416917B1 (el)
JP (1) JP4714412B2 (el)
KR (1) KR100914113B1 (el)
CN (1) CN1254233C (el)
AT (1) ATE365537T1 (el)
AU (1) AU2002317409B2 (el)
BR (1) BR0211705A (el)
CA (1) CA2456180C (el)
CY (1) CY1107059T1 (el)
DE (1) DE60220923T2 (el)
DK (1) DK1416917T3 (el)
ES (1) ES2287293T3 (el)
HK (1) HK1064048A1 (el)
IL (2) IL160103A0 (el)
MX (1) MXPA04001071A (el)
NO (1) NO20040484L (el)
NZ (1) NZ530916A (el)
PT (1) PT1416917E (el)
WO (1) WO2003013472A1 (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0230088D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0314057D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
WO2004111033A1 (en) * 2003-06-18 2004-12-23 Astrazeneca Ab 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
GB0314261D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
WO2006069098A1 (en) * 2004-12-22 2006-06-29 Elan Pharma International Ltd. Nanoparticulate bicalutamide formulations
EP1915131A4 (en) * 2005-08-12 2012-07-25 Astrazeneca Ab PROCESS
EP2054036B1 (en) 2006-07-24 2019-12-18 Singh-Broemer and Company, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
US20100260691A1 (en) * 2006-07-31 2010-10-14 Narayanan Kolazi S Aqueous compositions containing a hydrophobic material
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
EP2109443A4 (en) * 2007-02-09 2012-08-22 Astrazeneca Ab METHOD FOR PRODUCING A STABLE DISPERSION FROM SOLID AMORPHIC SUBMICRON PARTICLES IN AN AQUEOUS MEDIUM
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
TW200920347A (en) * 2007-07-16 2009-05-16 Poniard Pharmaceuticals Inc Oral formulations for picoplatin
CN101998851A (zh) * 2008-02-08 2011-03-30 帕纳德制药公司 吡铂和西妥昔单抗治疗结直肠癌的用途
BRPI1004808B1 (pt) * 2010-10-27 2020-09-29 Embrapa - Empresa Brasileira De Pesquisa Agropecuária Composições baseadas em nanopartículas de própolis, processos de obtenção e uso
CN109999013A (zh) 2012-02-29 2019-07-12 普马特里克斯营业公司 可吸入干粉剂
KR102045732B1 (ko) * 2012-12-28 2019-11-18 엘지디스플레이 주식회사 온도감응형 계면활성제를 이용한 수용성 나노입자의 제조방법
PT106738B (pt) 2013-01-09 2015-06-08 Hovione Farmaciencia Sa Método para o controlo do fenómeno de degradação difusional de ostwald (ostwald ripening) no processamento de partículas de um ingrediente farmacêutico
JP2016507542A (ja) * 2013-02-08 2016-03-10 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 反応型噴霧乾燥による無機／有機複合材料の製造
WO2019055525A1 (en) * 2017-09-12 2019-03-21 Raj Selvaraj FORMULATION OF SOLID NANOPARTICLES OF WATER-INSOLUBLE PHARMACEUTICAL SUBSTANCES WITH REDUCED OSTWALD CURING
KR20240093542A (ko) 2021-11-05 2024-06-24 싱클루스 파마 홀딩 에이비 (피유비엘) 리나프라잔 글루레이트의 염산염의 다형체

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2224131B2 (de) * 1972-05-17 1974-06-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Gewinnung des Enzyms Cholesterinoxydase, welches Cholesterin mit O tief 2 zu Cholestenon und H tief 2 O tief 2 oxydiert
US4348385A (en) * 1980-11-17 1982-09-07 Mobay Chemical Corporation Flowable pesticides
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
US4799962A (en) * 1987-12-24 1989-01-24 Aqualon Company Water-soluble polymer dispersion
EP0379591B1 (en) * 1988-06-28 1994-01-19 Matsushita Electric Industrial Co., Ltd. Exhaust smoke purifier apparatus
FR2651680B1 (fr) * 1989-09-14 1991-12-27 Medgenix Group Sa Nouveau procede de preparation de microparticules lipidiques.
CA2044706C (en) * 1990-06-15 2003-02-25 Michael Midler Jr. Crystallization method to improve crystal structure and size
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DK0615445T3 (da) * 1991-12-05 1996-06-03 Alfatec Pharma Gmbh Farmaceutisk administrerbar nanosol og fremgangsmåde til fremstilling deraf
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5468604A (en) * 1992-11-18 1995-11-21 Eastman Kodak Company Photographic dispersion
GB9319129D0 (en) * 1993-09-15 1993-11-03 Dowelanco Ltd Storage and dilution of stable aqueous dispersions
SE9303281D0 (sv) * 1993-10-07 1993-10-07 Astra Ab New formulation
SE9403846D0 (sv) * 1994-11-09 1994-11-09 Univ Ohio State Res Found Small particle formation
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5665331A (en) * 1995-01-10 1997-09-09 Nanosystems L.L.C. Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
ES2212083T3 (es) * 1996-10-03 2004-07-16 Hermes Biosciences, Inc. Microparticulas hidrofilas y procedimiento para prepararlas.
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
US6267989B1 (en) * 1999-03-08 2001-07-31 Klan Pharma International Ltd. Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US7037528B2 (en) * 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations

Also Published As

Publication number Publication date
DK1416917T3 (da) 2007-09-17
PT1416917E (pt) 2007-08-16
ATE365537T1 (de) 2007-07-15
EP1416917B1 (en) 2007-06-27
CY1107059T1 (el) 2012-10-24
JP2005500362A (ja) 2005-01-06
CN1254233C (zh) 2006-05-03
NO20040484L (no) 2004-03-31
IL160103A0 (en) 2004-06-20
KR20040025739A (ko) 2004-03-25
KR100914113B1 (ko) 2009-08-27
CA2456180A1 (en) 2003-02-20
CN1564677A (zh) 2005-01-12
MXPA04001071A (es) 2004-05-20
DE60220923D1 (de) 2007-08-09
DE60220923T2 (de) 2008-03-06
NZ530916A (en) 2005-07-29
CA2456180C (en) 2011-10-11
BR0211705A (pt) 2004-09-28
IL160103A (en) 2008-11-26
WO2003013472A1 (en) 2003-02-20
AU2002317409B2 (en) 2007-06-21
ES2287293T3 (es) 2007-12-16
EP1416917A1 (en) 2004-05-12
JP4714412B2 (ja) 2011-06-29
US20050009908A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
HK1064048A1 (en) Aqueous dispersion comprising stable nanoparticlesof a water-insoluble active and an excipient like middle chain triglycerides (mct)
AU2003291973A1 (en) A self-cleaning spray nozzle
WO2001003670A8 (de) Verfahren zur schonenden herstellung von hochfeinen mikropartikeln und nanopartikeln
EP2241308A3 (en) Method for coating fine particle with lipid membrane
WO2002060578A1 (fr) Dispositif servant a activer une substance au moyen d'une structure active et dispositif servant a generer un gaz
EP1829530A3 (en) Stabilization of active agents by formulation into nanoparticulate form
WO2005038948A3 (en) Nanosized silver oxide powder
WO2002035991A3 (en) Spherical particles produced by a hot-melt extrusion/spheronization process
MA25426A1 (fr) PROCéDé DE FABRICATION DE GRANULES ENROBéS GO T MASQUé ET LIBéRATION IMMéDIATE DU PRINCIPE ACTIF
WO2003003860A3 (en) Stabilized compositions and processes of their preparation
AU3764901A (en) Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
AU2003230658A1 (en) Microparticles and method for their production
EP1769867A4 (en) METHOD FOR PRODUCING METAL PARTICLES, METAL PARTICLES PRODUCED THEREwith, SELF-CONTAINING COMPOSITION, LIGHT ABSORBING MATERIAL AND APPLICATION THEREOF
GB0302673D0 (en) Pharmaceutical formulations
NO20060109L (no) Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning
WO2001062088A3 (en) Safening high concentrations of phytocatalysts
US10836984B2 (en) Method for stabilizing both lipase and protease in liquid enzymatic laundry detergent
MXPA02011741A (es) Eteres de celulosa con disolucion retardada y un procedimiento para su fabricacion.
EP1258254A4 (en) COMPOSITIONS FOR DELAYED DELIVERY OF PHYSIOLOGICALLY ACTIVE COMPOUNDS THAT ARE LOW WATER-SOLUBLE, METHOD FOR THE PRODUCTION AND USE THEREOF
AU5523599A (en) Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
AU2003277732A1 (en) Method for the preparation of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby
AU1479801A (en) Methods for rendering high concentrations of manganese safe for plant growth andformulations for same
WO2003066019A3 (de) Verfahren zur herstellung wasserdispergierbarer trockenpulver von in wasser schwer löslichen verbindungen
WO2006053564A3 (en) Stabilisation of granules comprising active compounds
AU6924501A (en) Method for isolating and purifying a protein and resulting protein

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE NAME OF THE INVENTOR FROM PIA MARGARETHA CECILIA HEDBERG AND ANNA ELISABETH ZACKRISSON TO PIA MARGARETHA CECILIA SKANTZE AND ANNA ELISABETH ZACKRISSON SCHANTZ

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120801